Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Ehud Baron

Ehud Baron

Chairman and President/CTO X-Cardio Corp. KK Japan

Remigijus Zaliunas

Remigijus Zaliunas

Lithuanian University of Health Sciences Lithuania

Yochai Birnbaum

Yochai Birnbaum

Baylor College of Medicine USA

Recommended Global Cardiology Webinars & Conferences

Asia Pacific & Middle East

CVDT 2023

About Conference

Conference Series invites worldwide global audience and presenters to participate at the 6th International Conference on Cardiovascular Diseases and Therapeutics which is to be held in Toronto, Canada during August 07-08, 2023. Special interest and theme of the conference is “Innovations in the treatment of Cardiovascular Disease”.

CVDT 2023 offers an excellent global platform for cardiovascular health professionals by organizing conferences, workshops, seminars, B2B sessions in addition to interactive gatherings from around the world with a wide range of discussions on innovative discoveries for advancing the aegis and medicines of the heart and vascular conditions.

We aim to provide an opportunity to share knowledge, expertise as well as unparalleled networking prospects among a large number of healthcare professionals such as directors, heads, deans, professors, scientists, researchers, cardiologists, founders and employees of the companies associates, associations, organizations, Members of the laboratory and young researchers working in the field of cardiology and cardiac treatment. This cardiology conference focuses primarily on raising awareness of the challenges in these areas and how to avoid and manage cardiac imaging, cardiology, and cardiac nursing techniques.

The Cardiology Conferences will provide a comprehensive update on all medical, surgical, interventional and electrophysiological topics in Cardiology and also provide an opportunity for clinicians, scientists, physicians and researchers from around the world to come together and learn the latest advancements in the field of cardiology and health care and to exchange scientific ideas and experiences in a distinctive environment.

Target Audience:

  • Cardiologists

  • Academicians

  • Research Scholars

  • Industrial Professionals

  • Academic Scientists

  • Pharmacologists

  • Business Delegates

  • Medical Students

  • Laboratory Technicians

  • Postdoctoral fellows and trainees Sonographers

  • Sonographers

Tracks and Sessions

Track 1: Heart Rhythm and Arrhythmia

A cardiac arrhythmia is an irregular heartbeat. Heart rhythm problems (cardiac arrhythmias) occur when the electrical signals that control the beating of the heart do not work properly. Faulty signaling causes the heart to beat too fast (tachycardia), too slow (bradycardia), or irregularly. Cardiac arrhythmias can feel like a beating or racing heart and can be harmless. However, some heart arrhythmias can be troublesome.

In a typical heartbeat, a tiny mass of cells at the sinus node sends an electrical signal. The signal then travels through the atria to the atrioventricular (AV) node and into the ventricles, causing them to engage and pump blood.

Track 2: Heart failure and cardiomyopathies

Heart failure, sometimes recognized as congestive heart failure, occurs when the heart muscle does not pump blood as efficiently as it can. Certain heart conditions, such as narrowed arteries in the heart (coronary artery disease) or high blood pressure, gradually leave the heart too weak or stiff to fill and pump blood properly. Not all conditions that lead to heart failure can be reversed, but treatments can advance the signs and symptoms of heart failure and allow people to live longer.

Cardiomyopathy is a group of diseases that damage the heart muscle. Primary there may be few or no symptoms. As the disease worsens, shortness of breath, feeling tired and swelling in the legs may occur, due to the onset of heart failure. Irregular heartbeat and fainting may occur. There is an increased risk of sudden cardiac death in affected individuals. Types of cardiomyopathy include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia, and Takotsubo cardiomyopathy (broken heart syndrome). In hypertrophic cardiomyopathy, the heart muscle enlarges and thickens. In dilated cardiomyopathy, the ventricles expand and weaken. In restrictive cardiomyopathy, the ventricle stiffens.

Track 3: Coronary Heart Diseases

Coronary heart disease is often called coronary artery disease, which means the narrowing of the coronary arteries or the buildup of plaque in the arteries. The coronary arteries are the blood vessels that supply oxygen and blood to the heart. The coronary arteries are vital: blood is carried to the coronary arteries by the heart muscle. So, as the coronary arteries narrow, blood flow to the muscles of the heart decreases. A common symptom is chest pain or discomfort that can spread to the shoulder, arm, back, neck, or jaw. Irregularly, it may feel like heartburn. Usually, symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest. Shortness of breath may also occur and sometimes no symptoms are present. In many cases, the first sign is a heart attack. Other complications include heart failure or abnormal heart rhythm.

Track 4: Acute coronary syndromes

Acute Coronary Syndrome (ACS) is a syndrome caused by decreased blood flow to the coronary artery (set of signs and symptoms) such that part of the heart muscle fails to function properly or dies. The most common symptom is chest pain, frequently radiating to the left shoulder or angle of the jaw, crushing, central, and associated with nausea and sweating. Many people with acute coronary syndrome, especially women, elderly patients, and patients with diabetes mellitus, have symptoms other than chest pain.

Acute coronary syndrome is generally related to three clinical symptoms, named according to the presence of the electrocardiogram (ECG): ST-segment elevation myocardial infarction (STEMI, 30%) and non-ST-segment elevation myocardial infarction ( NSTEMI, 25%) or unstable angina (38%). There can be several variations as to which forms of myocardial infarction (MI) are classified as acute coronary syndrome.

Track 5: Hypertension and health care

Hypertension is a condition in which the blood pressure in the arteries is constantly elevated at a regular rate. This is often referred to as high blood pressure or cardiovascular disease with vital signs or elevated blood vessels. This can lead to serious health problems and increase the risk of cardiovascular disease, stroke, and sometimes death. The different forms of cardiovascular diseases and their evaluation are mainly discussed in this session. Almost 90-95% of cases are primary and the unhealthy lifestyle followed by excess alcohol, salt, body weight, etc. The remaining 5-10% suffer from it due to thinning of the renal arteries, chronic kidney disease and endocrine disorders.Evaluation of cardiovascular disease typically involves confirmation of hypertension, risk factors, underlying causes, organ damage, and indications and contraindications for medications. Hypertension could be a major threat to heart disease and stroke.

Track 6: Cardiac regeneration

Cardiac regeneration is the ability of restorative stem cells to restore impaired tissue function by renewing cell growth in heart cells destroyed by heart disease or by rapidly growing and controversial research. The discovery of progenitor cells inside the heart about 12 years ago spurred interest in regenerative cell-based therapies, and about 15.5 million Americans suffer from one or more forms of cardiovascular disease, such as a heart attack, angina or heart failure. Here is the heart regeneration technique, which allows exogenous cells to be inserted into the damaged region of the heart. These transplanted cells could generate and repopulate the injured area with myocardium.

  • Cardiac regenerative therapy
  • Trans differentiation during cardiac regeneration
  • Biomimetic Heart Valve Replacement
  • Modified heart tissue derived from stem cells
  • NSTEMI Guidelines
  • Cardiomyocyte proliferation
  • Angiogenesis
  • Transcription
  • Creation of fabrics

Track 7: Interventional Cardiology and Cardiac Surgery

Interventional cardiology requires the correction of vessels, narrowed arteries, or other compromised parts of the heart system that are altered or weakened. This is a non-surgical care technique that uses a narrow flexible tube called a catheter. Through catheterization, the heart can be exposed to several procedures. This usually involves injecting a catheter into the heart system's cardiac chamber/coronary arteries/valves and cardiac cannulation under x-ray visualization or most often fluoroscopy. Scars, pain and long post-operative recovery are avoided by adapting this form of treatment. Due to prolonged fluoroscopy time and radiographic exposure, procedures used in interventional cardiology result in significant radiation doses to patients.

Surgery on the heart or large arteries is cardiac surgery or heart surgery. It is performed to resolve problems related to the heart. A heart surgeon is a specialist in heart surgery. Unlike conventional open-heart surgery, new methods of heart surgery (such as pumpless surgery and minimally invasive surgery) can minimize risk and speed up recovery time. Heart surgery is performed by a heart surgeon to repair or replace heart valves, repair irregular or damaged heart structures, insert medical devices that help regulate heart rate or support heart function and blood flow, or replace a heart damaged by a healthy donor heart.

  • Open heart surgery
  • Modern beating heart surgery
  • Coronary bypass graft
  • Minimally invasive surgery
  • Robot-assisted surgeries
  • Heart transplant
  • Angioplasty
  • Valvuloplasty

Track 8: Pediatric and neonatal cardiology

The goal of pediatric cardiology is to diagnose congenital heart defects, perform diagnostic procedures such as echocardiograms, cardiac catheterization, and electrophysiology studies, and manage the onset of heart disease in infants, children and adolescents on an ongoing basis. Myocarditis (the condition is characterized by inflammation of the heart muscle) involves different forms of inflammatory heart disease; Kawasaki disease is a rare childhood disease that affects blood vessels. Prenatal diagnosis and care for pregnant women at risk or suspected of carrying babies with heart defects is neonatal cardiology.

  • Pediatric cardiac catheterization
  • Disease risk and diagnosis
  • Pediatric angina
  • Pathology of pediatric diseases
  • Pediatric heart transplants
  • Pediatric cardiologists
  • Pediatric Cardiac Physiology

Track 9: Robotic heart surgery

Robotic heart surgery is heart surgery performed through very minor cuts in the chest. Through the use of tiny instruments and robot-controlled tools, surgeons are able to perform heart surgery in a vastly less invasive way than open-heart surgery. The procedure is sometimes called da Vinci surgery because that is the name of the robot manufacturer often used for this technique. Robotic surgeries have been used for a number of different cardiac procedures, including valve surgery, coronary bypass surgery, heart tissue removal, heart defect repair, and tumor removal.

Track 10: Cardiac Imaging

Cardiac Imaging, also known as Cardiovascular Magnetic Resonance Imaging (MRI), is a medical imaging technology for non-nosed assessment of the function and structure of the cardiovascular system with an imaging branch cardiovascular that clarifies cross-sectional imaging studies of the heart and blood vessels system using computed tomography (CT or 'CAT') and magnetic resonance imaging (MRI). CT and MRI are non-invasive imaging modalities that generate detailed images of structures inside the heart using a strong magnetic field, radio waves, and a computer. It is used in patients with congenital heart disease to diagnose or monitor heart disease and to assess the anatomy and function of the heart. To ensure optimal diagnostic quality in patient care while minimizing patient exposure to ionizing radiation, MUSC uses the latest state-of-the-art imaging instruments.

  • Cardiovascular Magnetic Resonance Imaging
  • Non-invasive cardiac imaging
  • Clinical Uses of Cardiac Imaging
  • Cardiac MRI
  • Physician impairment
  • Echocardiography
  • Magnetic Resonance Imaging (MRI)
  • Computed tomography (CT)
  • Imaging in nuclear medicine
  • Coronary catheterization
  • Intravascular ultrasound

Track 11: Cardio-oncology

Cancer and cardiovascular disease are leading causes of death in many parts of the world, and cardio-oncology is at the intersection of heart problems in cancer patients. For both diseases occurring in the same patient, there are many explanations. Risk factors for coronary heart disease (CD) and cancer include age, smoking and obesity. The effects of radiation therapy and chemotherapy in long-term survivors of a malignancy may be other causes. These treatments have a direct effect on the heart, which in some cases requires surgical correction. Malignancy may also occur during long-term follow-up after coronary artery bypass graft (CABG) surgery. The growth of medical facilities also makes the identification of heart disease and treatable cancers more likely.

  • Benign cardiac tumours, cardiac fibroma
  • Atrial myxoma, tricuspid stenosis
  • Cardiac tumour, pulmonary chondroma
  • Carney complex, LAMB syndrome
  • Prevention of chemotherapy-induced cardiac dysfunction
  • Cancer and heart

Track 12: Echocardiography

Echocardiography is called cardiac echo produced by the ultrasound waves which generate the images of the heart. It is a type of ultrasound test that uses high-pitched sound waves transmitted through a system called a transducer. The device accepts echoes of sound waves as they bind to different parts of the heart. These echoes tend to produce moving images of the heart that can be seen on a video screen. It helps to recognize cardiomyopathies, such as cardiomyopathy with hypertrophy, dilated cardiomyopathy and many others.

  • Cardiac Imaging Techniques
  • Cardiac Magnetic Resonance Imaging (MRI)
  • Three-dimensional echocardiography
  • Angiocardiography
  • Cardiopulmonary Exercise Test (CPET)
  • Heart rate monitor
  • Hypertrophic cardiomyopathy
  • Pacemaker monitoring
  • Stress echocardiography
  • Myocardial Perfusion Imaging

Track 13: Cardiac Nursing: Acute and Chronic Cardiac Care

Cardiac nursing is a discipline focused on the prevention and treatment of disorders, as well as an understanding of normal cardiac anatomy and physiology, extensive skills in assessment and monitoring, a thorough knowledge of diseases and cardiac disorders and ongoing training in appropriate prevention methods. treatment methods and options. Clinical nurse specialists and nurse practitioners provide comprehensive cardiovascular care to patients with acute and chronic heart disease.

Key areas include:

Critical care and acute care management of cardiac patients, advanced health assessment, clinical prevention and advanced pathophysiology.

  • Discussion of the role of nurses in the success of a heart failure service
  • Management of Cardiac Patients in Intensive Care and Acute Care
  • Advanced Health Assessment
  • Increase patient knowledge and education about the disease and its management

Track 14: Cardiac pharmacology

The Pharmacological study which concerned cardiac and neuronal drugs. Cardiac or cardiovascular pharmacology describes the activities of cardiac medicine in different heart diseases including cardiac arrhythmias, hypertension, congestive heart failure, angina, and cardiomyopathy. Neuronal pharmacology focuses on neurological disorders and their drug pharmacological activities. There is a physiological relationship between these cardiac and neuropharmacological disorders since almost all cardiac disorders are interrelated with the nervous system. The heart system is internally regulated by the sympathetic and parasympathetic nervous systems.

  • Pharmacotherapy for cardiac arrhythmias
  • Pharmacotherapy for acute and chronic heart failure
  • Drug treatment of systemic hypertension
  • Anti-ischemic drug therapy

Track 15: Nuclear cardiology

Nuclear cardiology is the study of myocardial perfusion scans, and this test is used to monitor blood flow in the heart muscle. If these arteries are blocked, the coronary arteries carry blood to the heart muscle, so the heart does not get enough blood to function properly. Coronary artery disease (CAD) results from this blockage. Myocardial perfusion ultrasound is divided into two sections, which are stress ultrasound and rest ultrasound. The primary reason for early diagnosis of heart disease and assessment of disease extent and detection of findings in the setting of coronary artery disease is nuclear cardiology. Nuclear cardiology studies use non-invasive techniques to analyze myocardial blood flow, assess the pumping mechanism of the heart, and imagine the size and location of a heart attack. Myocardial perfusion imaging is the most widely used nuclear cardiology technique. For many cancer survivors, cardiovascular disease emerges as an important cause of death, rivaling cancer recurrence. This improvement in cancer survival has promoted robust cancer survival, associated with off-target side effects of oncology therapies and the availability of strategies to improve cardiovascular outcomes.

  • Myocardial infarction
  • Vasodilators
  • Percutaneous Coronary Intervention (PCI)
  • Magnetic resonance imaging
  • Perfusion

Track 16: Sports and exercise medicine

Over the years, sports medicine has expanded to include not only competitive athletes, but also anyone who exercises (amateur or professional). Although sport can impart heroic fitness to athletes, there is a risk of sport-related sudden cardiac death. The societal and media response to these tragic athlete deaths is garnering negative publicity, although the overall benefits of exercise outweigh the risks. Generally, sudden cardiac death is triggered by a malignant tachyarrhythmia such as ventricular fibrillation (VF) or ventricular tachycardia degenerating into VF. There is usually an underlying substrate for triggering the arrhythmia, such as hypertrophic cardiomyopathy, channelopathies, arrhythmogenic cardiomyopathy, or congenital coronary artery anomalies, among others.

Market Analysis

The global cardiovascular drugs market size is expected to reach approximately USD 231.7 billion by 2030, from a value of USD 155.6 billion in 2021 and growing at a CAGR of 4.52% between 2022 and 2030.

According to Precedence Research, the global cardiovascular drug market size stood at $162.64 billion in 2022. Rapid modernization has increased the consumption of fast foods and unhealthy lifestyles, which has increased the number of cases with cardiovascular disorders. Lack of physical activity in people due to a busy schedule increases the rate of cardiovascular disorders. This leads to an increase in demand and supply of essential cardiovascular drugs which prove to be life-saving for patients. Many cardiovascular disorders require palliative treatment which is helping to boost the market.

Cardiovascular medications cannot be discontinued easily by a patient as it requires good judgment of the patient's heart health, which can prove fatal in the long run. Therefore, cardiovascular drugs are finding an important place in the healthcare industry market.

CVDT 2023 Graph

Regional overviews

The North American market has witnessed the highest growth due to the large number of populations suffering from cardiovascular diseases. The increasing prevalence of hypertension in people along with obesity has led to many cardiovascular disorders. The Asia-Pacific region has proven to be the fastest growing market for cardiovascular drugs due to the large number of people with hypertension. Obesity is another factor that leads to cardiovascular disorders that drive the sales of cardiovascular drugs.

The European market has seen considerable growth due to the large number of elderly people in this region. The presence of the genetic population automatically propels the demand and supply chain of the cardiovascular drug market.

Report Highlights

On the basis of drug type, Antihypertensives dominated the segment owing to its high demand in the market due to habitual consumer consumption which cannot be discontinued under any circumstances. The large number of people with hypertension has boosted this market.

Based on disease indication, the hypertension segment led the segment due to its huge prevalence among the population, which also includes young people. Hyperlipidemia also provides a huge market due to the unhealthy lifestyle of the people.

Based on end users, the hospital sector has seen the highest growth because it is the first place a patient goes in an emergency. The use of high-grade life-saving drugs and drugs is helping the cardiovascular drug market to show significant growth.

On the basis of geography, the North America market has witnessed phenomenal growth owing to the large number of cardiovascular patients present in this region. The use of advanced drugs has increased the lifespan of people with cardiovascular disorders, which has kept the demand and supply of essential drugs alive.

Past Conference Report

CVDT 2022:

We would like to thank all of our wonderful presenters, conference attendees, and students for helping to make the CVDT 2022 Conference the greatest ever!

The "5th International Conference on Cardiovascular Diseases and Therapeutics" took place in Australia on July 13-14, 2022. The generous response from journal Editorial Board Members, as well as scientists, researchers, students, and leaders from diverse fields of Cardio Vascular Diseases, made this event a huge success. All Editorial Board Members of "Cardiovascular Diseases & Diagnosis" are acknowledged with gratitude and support for their significant contributions for the Organization's growth.

The conference began with the honourable presence of the Keynote forum. Heartfelt thanks to the Organising Committee Associates, many external specialists, company representatives, and other renowned individuals who assisted the conference by facilitating discussion sessions. We also had the opportunity to thank the members of the Organising Committee, Editorial Board, and Media Partners who helped make this event possible.

Following the success of CVDT 2022, the "6th International Conference on Cardiovascular Diseases and Therapeutics" will be held in Toronto, Canada on August 07-08, 2023. CVDT 2023 was organised with the goal and special intent of promoting the creation of fresh perspectives and ideas for capitalising on the scientific community's high level of Awareness in various Cardio Vascular Disease domains.

Let us meet at @ CVDT 2023

To Collaborate Scientific Professionals around the World

Conference Date August 07-08, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Cardiovascular Diseases & Diagnosis Cardiovascular Pharmacology Journal of Vascular Diseases and Treatment

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner